Annual Report

Overview

The report highlights approximately RMB1,948 million of 2024 Group revenue, a 30% increase, and continued expansion of innovative-drug R&D and international commercialization. It reports RMB4.2355 million invested in environmental protection and total Scope 1 plus Scope 2 GHG emissions of 26,800.75 tCO2e. The company also reports 100% work safety training coverage and female employees representing 52.4% of employees.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: Ends 31 December 2024
Publication date: 27 March 2025
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services